The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome

被引:25
作者
Celik, Cem [1 ]
Bastu, Ercan [2 ]
Abali, Remzi [1 ]
Alpsoy, Seref [3 ]
Guzel, Eda Celik [4 ]
Aydemir, Birsen [5 ]
Yeh, John [6 ]
机构
[1] Namik Kemal Univ, Fac Med, Dept Gynecol & Obstet, Tekirdag, Turkey
[2] Istanbul Univ, Fac Med, Dept Gynecol & Obstet, Istanbul, Turkey
[3] Sakarya Univ, Fac Med, Dept Cardiol, Sakarya, Turkey
[4] Sakarya Univ, Fac Med, Dept Biophys, Sakarya, Turkey
[5] Istanbul Univ, Cerrahpasa Fac Med, Dept Biophys, Istanbul, Turkey
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA USA
关键词
Brachial artery flow mediated dilation; carotid intima-media thickness; copper; homocysteine; polycystic ovary syndrome; ATHEROSCLEROSIS; ENDOTHELIUM;
D O I
10.3109/09513590.2013.774361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study investigates copper (Cu) levels and vascular dysfunction in lean women with polycystic ovary syndrome (PCOS). 44 subjects with PCOS, diagnosed according to Rotterdam criteria, and 42 healthy subjects matched for body mass index and age. Comparison of serum Cu, homocysteine, carotid intima-media thickness (CIMT), brachial artery flow mediated dilation (FMD) was carried out between PCOS patients and the control group. Clinical study was done in Namik Kemal University School of Medicine. The CIMT and concentration of Cu in PCOS patients was significantly higher than the healthy controls. FMD levels in PCOS patients were significantly lower than those in controls. In PCOS patients, CIMT was correlated with estrogen and Cu levels. However, FMD was correlated with age and Cu levels. Among these contributing factors, Cu levels were correlated with a change in CIMT and FMD. CIMT and FMD in PCOS patients were related to Cu levels as well as several cardiovascular risk factors. Thus, increased Cu levels may be responsible for the increased risk of early vascular disease in women with PCOS.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 27 条
[1]  
Aalbers THG, 1981, SCI TOTAL ENVIRON, V43, P255
[2]   HOMOCYSTEINE AND VASCULAR-DISEASE [J].
BERWANGER, CS ;
JEREMY, JY ;
STANSBY, G .
BRITISH JOURNAL OF SURGERY, 1995, 82 (06) :726-731
[3]   Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease [J].
Boulman, N ;
Levy, Y ;
Leiba, R ;
Shachar, S ;
Linn, R ;
Zinder, O ;
Blumenfeld, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2160-2165
[4]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[5]   Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women [J].
Coskun, Ayhan ;
Ercan, Onder ;
Arikan, Deniz Cemgil ;
Ozer, Ali ;
Kilinc, Metin ;
Kiran, Gurkan ;
Kostu, Bulent .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 154 (02) :167-171
[6]   Cardiovascular disease risk factors in polycystic ovary syndrome [J].
Dokras, Anuia .
SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (01) :39-44
[7]   INCREASED PLASMA COPPER IN PATIENTS WITH HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY [J].
DUDMAN, NPB ;
WILCKEN, DEL .
CLINICA CHIMICA ACTA, 1983, 127 (01) :105-113
[8]   Medical progress: Polycystic ovary syndrome [J].
Ehrmann, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1223-1236
[9]   Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta [J].
Emsley, AM ;
Jeremy, JY ;
Gomes, GN ;
Angelini, GD ;
Plane, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (04) :1034-1040
[10]   Hyperhomocysteinemia and the endocrine system: Implications for atherosclerosis and thrombosis [J].
Fonseca, V ;
Guba, SC ;
Fink, LM .
ENDOCRINE REVIEWS, 1999, 20 (05) :738-759